breast cancer and glp-1 Receptor Agonists in Cancer: Moving Beyond Weight Loss Toward Prevention Survivorship glp-1 breast cancer recurrence Recent

Patients, doctors and researchers are making observations about a range of new potential uses

Not to mention: the astronomical cost of medical services and medication

1,2 The use of these medications is rapidly expanding as they gain in popularity and receive FDA approvals across multiple disease states

Proc Natl Acad Sci U S A, 89 , 2399-403

The result is enhanced cell migration, meaning repair cells can actually reach damaged tissue more efficiently

Insurance coverage often limits which specific medications are covered, potentially forcing patients to use less optimal options based on formulary restrictions rather than clinical needs